title: Dopaminagonists and fibrotic valvular heart disease: further considerations.
authors.forename: Olivier
authors.initials: O
authors.lastname: Rascol
authors.forename: Atul
authors.initials: A
authors.lastname: Pathak
authors.forename: Haleh
authors.initials: H
authors.lastname: Bagheri
authors.forename: J-L
authors.initials: JL
authors.lastname: Montastruc
mesh_terms: D018491:Dopamine Agonists / Q000009:adverse effects*; D005355:Fibrosis / Q000139:chemically induced*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000009:adverse effects*
chemical_list: D018491:Dopamine Agonists; D010479:Pergolide